Suppr超能文献

帕金森病中的精神病和抗精神病药物初治精神分裂症谱系精神病中的帕金森综合征:临床、分类学和病理生物学挑战。

Psychosis in Parkinson's disease and parkinsonism in antipsychotic-naive schizophrenia spectrum psychosis: clinical, nosological and pathobiological challenges.

机构信息

School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, 2, Ireland.

Jiangsu Key Laboratory of Translational Research & Therapy for Neuro-Psychiatric Disorders and Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, China.

出版信息

Acta Pharmacol Sin. 2020 Apr;41(4):464-470. doi: 10.1038/s41401-020-0373-y. Epub 2020 Mar 5.

Abstract

Following the formulation of operational criteria for the diagnosis of psychosis in Parkinson's disease, a neurodegenerative disorder, the past decade has seen increasing interest in such nonmotor psychopathology that appears to be independent of dopaminergic therapy. Similarly, there has been a resurgence of interest in motor aspects of the neurodevelopmental disorder of schizophrenia, including spontaneous parkinsonism that appears to be independent of antipsychotic treatment. This review first addresses the clinical and nosological challenges of these superficially paradoxical insights and then considers pathobiological challenges. It proposes that diverse modes of disturbance to one or more element(s) in a cortical-striatal-thalamocortical neuronal network, whether neurodegenerative or neurodevelopmental, can result in movement disorder, psychosis or both. It then proposes that time- and site-dependent dysfunction in such a neuronal network may be a generic substrate for the emergence of psychosis not only in Parkinson's disease and schizophrenia-spectrum disorders but also in other neuropsychiatric disorders in which psychosis, and sometimes movement disorders, can be encountered; these include substance abuse, cerebrovascular disease, cerebral trauma, cerebral neoplasia, epilepsy, Huntington's disease, frontotemporal dementia, Alzheimer's disease and multiple sclerosis.

摘要

在制定了用于诊断帕金森病(一种神经退行性疾病)中精神病的操作标准后,过去十年中,人们对似乎独立于多巴胺能治疗的这种非运动性精神病理学越来越感兴趣。同样,人们对精神分裂症的神经发育障碍的运动方面重新产生了兴趣,包括似乎独立于抗精神病药物治疗的自发性帕金森病。这篇综述首先讨论了这些表面上矛盾的观点在临床和分类学方面的挑战,然后考虑了病理生物学方面的挑战。它提出,无论是神经退行性还是神经发育性,对皮质-纹状体-丘脑-皮质神经元网络中的一个或多个元素的多种干扰模式都可能导致运动障碍、精神病或两者兼而有之。然后,它提出这种神经元网络的时间和部位依赖性功能障碍可能是精神病出现的一般基础,不仅在帕金森病和精神分裂症谱系障碍中如此,而且在其他可能出现精神病和运动障碍的神经精神障碍中也是如此;这些障碍包括物质滥用、脑血管疾病、脑创伤、脑肿瘤、癫痫、亨廷顿病、额颞叶痴呆、阿尔茨海默病和多发性硬化症。

相似文献

2
Parkinson's disease psychosis: presentation, diagnosis and management.帕金森病性精神病:表现、诊断与管理
Neurodegener Dis Manag. 2017 Dec;7(6):365-376. doi: 10.2217/nmt-2017-0028. Epub 2017 Nov 21.
6
The management of psychosis in movement disorder patients.运动障碍患者的精神病管理
Expert Opin Pharmacother. 2007 May;8(7):935-43. doi: 10.1517/14656566.8.7.935.

引用本文的文献

7
Inflammation, Dopaminergic Brain and Bilirubin.炎症、多巴胺能脑与胆红素。
Int J Mol Sci. 2023 Jul 14;24(14):11478. doi: 10.3390/ijms241411478.

本文引用的文献

3
Hallucinations, Delusions and Impulse Control Disorders in Parkinson Disease.幻觉、妄想和帕金森病中的冲动控制障碍。
Clin Geriatr Med. 2020 Feb;36(1):105-118. doi: 10.1016/j.cger.2019.09.004. Epub 2019 Sep 6.
8
Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms.精神分裂症、多巴胺与纹状体:从生物学到症状。
Trends Neurosci. 2019 Mar;42(3):205-220. doi: 10.1016/j.tins.2018.12.004. Epub 2019 Jan 6.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验